About: covid:8ab3a297f1c135e531e93d2289299f99093cf4a8

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:8ab3a297f1c135e531e93d2289299f99093cf4a8 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	Ba, Albertson-Junkans, Ladia Dublin, Sascha Floyd, James Fuller, Sharon Green, Beverly Greenwood-Hickman, Mikael Harrington, Laura Psaty, Bruce Shortreed, Susan Walker, Rod Washington, Kaiser
is schema:about of	named entity 'healthcare system' named entity 'retrospective cohort study' named entity 'developed' named entity 'infection' named entity 'compared' named entity '95% CI' named entity 'COVID-19' named entity 'current' named entity 'INCREASE' named entity '0.75' named entity 'DAILY' named entity '283' named entity '322' named entity 'CURRENT' named entity 'PEOPLE' named entity 'HOSPITALIZED' named entity 'DAILY DOSE' named entity 'LABORATORY' named entity 'DOSES' named entity 'ACROSS' named entity 'INDIVIDUALS' named entity 'ARB' named entity 'CONFIDENCE INTERVALS' named entity 'ANGIOTENSIN RECEPTOR BLOCKERS' named entity 'IDENTIFIED' named entity 'COVID-19' named entity 'ESTIMATE' covid:arg/8ab3a297f1c135e531e93d2289299f99093cf4a8 named entity 'data' named entity 'conducted' named entity 'doses' named entity 'calculated' named entity 'relation' named entity 'ACEI' named entity 'defined daily dose' named entity 'angiotensin-converting enzyme inhibitors' named entity 'infection' named entity 'infection' named entity 'ACEI' named entity '1.26' named entity 'retrospective cohort study' named entity 'ACEI' named entity 'angiotensin-converting enzyme inhibitors' named entity '95% CI' named entity 'pharmacy' named entity 'defined daily dose' named entity 'ACEIs' named entity 'medRxiv' named entity 'protein' named entity 'angiotensin receptor blockers' named entity 'COVID' named entity 'COVID' named entity 'retrospective cohort study' named entity 'COVID-19 testing' named entity 'RAAS' named entity 'RAAS' named entity 'Austria' named entity 'COVID-19' named entity 'angiotensin converting enzyme inhibitors' named entity 'ACEI' named entity 'heart failure' named entity 'medRxiv' named entity 'COVID' named entity '95% CI' named entity 'infection' named entity 'polymerase chain reaction (PCR) test' named entity 'Italy' named entity 'ARBs' named entity 'angiotensin converting enzyme 2' named entity 'RAAS' named entity 'renin-angiotensin-aldosterone' named entity 'infection' named entity 'ARBs' named entity 'infection' named entity 'RAAS' named entity 'medRxiv' named entity 'pharmacies' named entity 'COVID' named entity 'thiazides' named entity 'Syneos Health' named entity 'severely obese' named entity 'systematic review' named entity 'malignancy' named entity 'angiotensin converting enzyme inhibitors' named entity 'pharmacy' named entity 'adverse effect' named entity 'infection' named entity 'Demographic characteristics'

Attributes

Values

Creator

Ba,
Albertson-Junkans, Ladia
Dublin, Sascha
Floyd, James
Fuller, Sharon
Green, Beverly
Greenwood-Hickman, Mikael
Harrington, Laura
Psaty, Bruce
Shortreed, Susan
Walker, Rod
Washington, Kaiser

is schema:about of

named entity 'healthcare system'
named entity 'retrospective cohort study'
named entity 'developed'
named entity 'infection'
named entity 'compared'
named entity '95% CI'
named entity 'COVID-19'
named entity 'current'
named entity 'INCREASE'
named entity '0.75'
named entity 'DAILY'
named entity '283'
named entity '322'
named entity 'CURRENT'
named entity 'PEOPLE'
named entity 'HOSPITALIZED'
named entity 'DAILY DOSE'
named entity 'LABORATORY'
named entity 'DOSES'
named entity 'ACROSS'
named entity 'INDIVIDUALS'
named entity 'ARB'
named entity 'CONFIDENCE INTERVALS'
named entity 'ANGIOTENSIN RECEPTOR BLOCKERS'
named entity 'IDENTIFIED'
named entity 'COVID-19'
named entity 'ESTIMATE'
covid:arg/8ab3a297f1c135e531e93d2289299f99093cf4a8
named entity 'data'
named entity 'conducted'
named entity 'doses'
named entity 'calculated'
named entity 'relation'
named entity 'ACEI'
named entity 'defined daily dose'
named entity 'angiotensin-converting enzyme inhibitors'
named entity 'infection'
named entity 'infection'
named entity 'ACEI'
named entity '1.26'
named entity 'retrospective cohort study'
named entity 'ACEI'
named entity 'angiotensin-converting enzyme inhibitors'
named entity '95% CI'
named entity 'pharmacy'
named entity 'defined daily dose'
named entity 'ACEIs'
named entity 'medRxiv'
named entity 'protein'
named entity 'angiotensin receptor blockers'
named entity 'COVID'
named entity 'COVID'
named entity 'retrospective cohort study'
named entity 'COVID-19 testing'
named entity 'RAAS'
named entity 'RAAS'
named entity 'Austria'
named entity 'COVID-19'
named entity 'angiotensin converting enzyme inhibitors'
named entity 'ACEI'
named entity 'heart failure'
named entity 'medRxiv'
named entity 'COVID'
named entity '95% CI'
named entity 'infection'
named entity 'polymerase chain reaction (PCR) test'
named entity 'Italy'
named entity 'ARBs'
named entity 'angiotensin converting enzyme 2'
named entity 'RAAS'
named entity 'renin-angiotensin-aldosterone'
named entity 'infection'
named entity 'ARBs'
named entity 'infection'
named entity 'RAAS'
named entity 'medRxiv'
named entity 'pharmacies'
named entity 'COVID'
named entity 'thiazides'
named entity 'Syneos Health'
named entity 'severely obese'
named entity 'systematic review'
named entity 'malignancy'
named entity 'angiotensin converting enzyme inhibitors'
named entity 'pharmacy'
named entity 'adverse effect'
named entity 'infection'
named entity 'Demographic characteristics'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software